According to Marketwatch, 54.23% of CRTX Cortexyme stock float is shorted.
My price target is a short squeeze to 29.5usd.
Looking forward to read your opinion about it.
65% SI on $CRTX according to latest S3 data.
RSI divergent to price action, MACD is crossing, OBV increasing steadily.
An inverted Head and Shoulders is about to form.
This thing will pop soon.
$CRTX – SI 55%
WAVE ANALYSIS is based on the notion that markets follow specific patterns called waves which are the result of a natural rhythm of crowd psychology that exists in all markets. ... This last wave is usually traded and its length can be predicted based on prior waves.
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing...
CRTX, Cortexyme, has one of the highest short floated in the market, 51.19%.
The only one with a higher short interest could be BKKT.
Price Target 1: $21.40
Price Target 2: $30.50
Stop loss: $10.50
Looking forward to read your opinion about it
This stock will likely moon or tank once the trial results of phase 2/3 are presented mid Nov.
Currently playing this with cash secured puts (Nov 19) to collect on the high premiums (~500% IV).
This is a risky play
Possible move:50%+
Reward/Risk: 10(R/R>3 is Ideal)
Time frame: 12wks
This is just my technical view, not a fundamental comment..!
I can make you confused by a crowded messy chart, but I would rather simple effective presentations..!
Insider buys Continue in the stock
EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Jun 12 Buy 44.06 2,440 $107,506
EPIQ Capital Group, LLC IA/Managing Member of 10% Owne Jun 11 Buy 44.32 6,600 $292,512
PLEASE GIVE US A LIKE IF YOU FIND OUT CONTENT HELPFUL, THANK YOU.
Will look for some movement in the stock post the vote of confidence by Director David Lamond
Insider Buy
Lamond David Director Jun 04 Buy 43.27 49,125 2,125,795 1,747,109
Short interest 16.5%
Company Profile
Cortexyme, Inc. is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other...
Please bear with me (or bull with me in a year) as I am new to this. I am new to investing and have been following biotech IPOs recently. I am just starting to learn technical analysis so I will have to update this later when there is more data to analyze and when I learn how to do that. Also disclaimer: I have an MD background but do not have any stake in this...
Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
NASDAQ
